BioPharma Services, Inc.

St Louis, Missouri 63141

0 studies enrolling now · 1 studies all time

What they study most

Relapsing Remitting Multiple Sclerosis

Studies at this site

• Bioequivalence Study of Bafiertam 190 mg and Vumerity® 462 mg Delayed-Release Capsules in Fasting Healthy Subjects — Completed